Zobrazeno 1 - 9
of 9
pro vyhledávání: '"MESH: Cystectomy"'
Autor:
Sophie Abadie-Lacourtoisie, Thierry Nguyen-Tan-Hon, Jean-Philippe Spano, Olivier Huillard, Nadine Houede, Hakim Mahammedi, Eric Voog, Yohann Loriot, Tifenn Lharidon, Sheik Emambux, Stéphane Culine, Lionnel Geoffrois, Jean-Christophe Eymard, Mounira El Demery, V. Harter, Vesper Trial Investigators, Philippe Barthélémy, Brigitte Laguerre, Yves Allory, Christine Chevreau, Aline Guillot, Florence Joly, Frédéric Di Fiore, Carolina Saldana, Gwenaelle Gravis, Christian Pfister, Werner Hilgers, Camille Serrate, Guilhem Roubaud, Sabine Vieillot, Aude Fléchon, Frederic Rolland
Publikováno v:
Clinical Genitourinary Cancer
Clinical Genitourinary Cancer, 2021, 19 (6), pp.554-562. ⟨10.1016/j.clgc.2021.08.005⟩
Clinical Genitourinary Cancer, 2021, 19 (6), pp.554-562. ⟨10.1016/j.clgc.2021.08.005⟩
Background : Cisplatin-based combination chemotherapy before surgery is the standard of care for muscle-invasive bladder cancer. However, the optimal chemotherapy modalities have not been precisely defined to date. Patients and Methods : In the VESPE
Autor:
Fraisse, Guillaume
Publikováno v:
Médecine humaine et pathologie. 2018
Introduction : la sarcopénie évaluée à partir de la mesure de l’indice de masse musculaire striée (SMI) a été étudié comme facteur prédictif de morbi-mortalité en chirurgie. L’objectif de cette étude était d’évaluer si elle était
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2592::a820a1d2772a9d24add8b68871094251
https://dumas.ccsd.cnrs.fr/dumas-02052122/file/ThExe_FRAISSE_Guillaume_DUMAS.pdf
https://dumas.ccsd.cnrs.fr/dumas-02052122/file/ThExe_FRAISSE_Guillaume_DUMAS.pdf
Autor:
Pignot, G., Houédé, N., Roumiguié, M., Audenet, F., Brunelle, S., Colin, P., Comperat, E., Larre, S., Masson-Lecomte, A., Neuzillet, Y., Xylinas, E., Méjean, A., Roupret, M.
Publikováno v:
Progrès en Urologie
Progrès en Urologie, Elsevier Masson, 2018, 28 (12), pp.567-574. ⟨10.1016/j.purol.2018.07.003⟩
Progrès en Urologie, Elsevier Masson, 2018, 28 (12), pp.567-574. ⟨10.1016/j.purol.2018.07.003⟩
International audience; INTRODUCTION:Neoadjuvant chemotherapy (NAC) is recommended for localized muscle-invasive bladder cancer when patients are fit for cisplatin-based chemotherapy. A pathological complete response can be observed, corresponding to
Publikováno v:
Médecine humaine et pathologie. 2018
Introduction: platinum-based Neo Adjuvant Chemotherapy (NAC) before Radical Cystectomy (RC) is the gold standard in the treatment of Muscle Invasive Bladder Cancer (MIBC). We aimed to compare the peri operative morbidity in patients treated by NAC th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2592::ab752f2439595322ec9806a9f2889ba3
https://dumas.ccsd.cnrs.fr/dumas-01893431/file/ThExe_PERINET-MARQUET_Constance_DUMAS.pdf
https://dumas.ccsd.cnrs.fr/dumas-01893431/file/ThExe_PERINET-MARQUET_Constance_DUMAS.pdf
Autor:
P. Martin, Jean-Léon Lagrange, Llacer Moscardo C, D. Azria, Norbert Ailleres, Bruno Chauvet, Pascal Fenoglietto, O. Riou, M. Charissoux, O. Lauche
Publikováno v:
Cancer/Radiothérapie
Cancer/Radiothérapie, Elsevier Masson, 2016, 20, pp.S196-S199. ⟨10.1016/j.canrad.2016.07.010⟩
Cancer Radiothérapie
Cancer Radiothérapie, Elsevier Masson, 2016, 20, pp.S196-S199. ⟨10.1016/j.canrad.2016.07.010⟩
Cancer/Radiothérapie, Elsevier Masson, 2016, 20, pp.S196-S199. ⟨10.1016/j.canrad.2016.07.010⟩
Cancer Radiothérapie
Cancer Radiothérapie, Elsevier Masson, 2016, 20, pp.S196-S199. ⟨10.1016/j.canrad.2016.07.010⟩
International audience; Surgery (radical cystectomy) is the standard treatment of muscle-invasive bladder cancer. Radiochemotherapy has risen as an alternative treatment option to surgery as part as organ-sparing combined modality treatment or for pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::805dd56c71e1974527e59f95ed30d11c
https://hal.umontpellier.fr/hal-02299039
https://hal.umontpellier.fr/hal-02299039
Autor:
Giovanni L. Pappagallo, David Azria, Orazio Caffo, Maria De Santis, Enzo Galligioni, Ananya Choudhury, Borut Kragelj, Daniel A. Hamstra, Gianni Fellin, C. Thompson
Publikováno v:
Radiotherapy and Oncology
Radiotherapy and Oncology, Elsevier, 2016, 121 (2), pp.193-198. ⟨10.1016/j.radonc.2016.09.006⟩
Radiotherapy and Oncology, Elsevier, 2016, 121 (2), pp.193-198. ⟨10.1016/j.radonc.2016.09.006⟩
International audience; PURPOSE:Although radical cystectomy is still considered the standard of care for most localized muscle-invasive bladder cancer (MIBC) patients, bladder-sparing strategies with chemoradiotherapy have demonstrated comparable loc
Autor:
Y, Nguyen-Huu, G, Delorme, J, Lillaz, I, Bedgedjian, I, Le Ray-Ferrières, E, Chabannes, S, Bernardini, G, Guichard, H, Bittard, F, Kleinclauss
Publikováno v:
Progrès en Urologie
Progrès en Urologie, Elsevier Masson, 2012, 22 (5), pp.284-90. 〈10.1016/j.purol.2011.10.002〉
Progrès en Urologie, Elsevier Masson, 2012, 22 (5), pp.284-90. ⟨10.1016/j.purol.2011.10.002⟩
Progrès en Urologie, Elsevier Masson, 2012, 22 (5), pp.284-90. 〈10.1016/j.purol.2011.10.002〉
Progrès en Urologie, Elsevier Masson, 2012, 22 (5), pp.284-90. ⟨10.1016/j.purol.2011.10.002⟩
International audience; OBJECTIVES: To study the prognostic impact of muscularis mucosae (MM) invasion for pT1 bladder cancer treated by transurethral resection (TUR) and adjuvant Bacille Calmette-Guerin (BCG) intravesical immunotherapy. METHODS: Six
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::6ab4bbdd4b633773a525f272250273c0
http://www.hal.inserm.fr/inserm-00864166
http://www.hal.inserm.fr/inserm-00864166
Autor:
Irani, J., Bernardini, S., Davin, J.-L., Guy, L., Mazerolles, C., Pfister, Christian, Roupret, M., Roy, C., Rozet, F., Saint, F., Théodore, C., Wallerand, H., Renseigné, Non
Publikováno v:
Progrès en Urologie
Progrès en Urologie, Elsevier Masson, 2008, 18 (4), pp.204-205. 〈10.1016/j.purol.2008.03.002〉
Progrès en Urologie, Elsevier Masson, 2008, 18 (4), pp.204-205. ⟨10.1016/j.purol.2008.03.002⟩
Progrès en Urologie, Elsevier Masson, 2008, 18 (4), pp.204-205. 〈10.1016/j.purol.2008.03.002〉
Progrès en Urologie, Elsevier Masson, 2008, 18 (4), pp.204-205. ⟨10.1016/j.purol.2008.03.002⟩
International audience; "Superficial bladder tumours" term is progressively abandoned in the urological community because of its ambiguity leading possibly to harmful confusions. The French Oncologic Society proposes to designate by non-infiltrating
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::16ad7dcededcd8b84199e4d2a272903a
https://hal.archives-ouvertes.fr/hal-00487278
https://hal.archives-ouvertes.fr/hal-00487278
Autor:
Jean-Jacques Patard, Henry Botto, Evanguelos Xylinas, Jeremy Crew, Christian Pfister, Karim Bensalah, Vincent Flamand, Pascal Rischmann, Michel Soulié, François-Xavier Nouhaud, Benoit Peyronnet, Julien Casenave, François Iborra, François Rozet, Laurent Salomon, Stéphane Larré, Morgan Rouprêt, Stéphane Droupy, Hervé Wallerand, Sophie Ferlicot, Aurélie Paule Floch, Maryam Hitier, Yann Neuzillet, Laura Poissonnier, Pascale Grès, Luc Cormier, Jacques Irani, Jean-Nicolas Cornu, Xavier Durand, Sarah J. Drouin, Cyrille Bastide, Pierre Lunardi, Jérôme Rigaud, Denis Champetier
Publikováno v:
Annals of Surgical Oncology
Annals of Surgical Oncology, Springer Verlag, 2011, 18 (13), pp.3833-8. ⟨10.1245/s10434-011-1824-y⟩
Annals of Surgical Oncology, Springer Verlag, 2011, 18 (13), pp.3833-8. ⟨10.1245/s10434-011-1824-y⟩
International audience; PURPOSE: To assess the postsurgical survival of patients with urothelial carcinoma of the bladder with pT0 tumor at pathologic examination of cystectomy specimens. METHODS: A multi-institutional, retrospective database was ana